A significant subset of AML with an NPM1 mutation shows an “APL-like” immune profile (CD15-/CD34-/HLA-DR-/strong myeloperoxidase) [15,75,76,77,78]. This evidence concerns the gene NPM1 and acute myeloid leukemia.